23.02.2023 - Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it plans to release 2022 financial results and provide a .
11.01.2023 - Call Scheduled for 11:00 a.m. Eastern Time on Tuesday, January 31, 2023DALLAS, Jan. 11, 2023 (GLOBE NEWSWIRE) - Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company .